.png)
Lighthouse
Blood-based Biomarkers in Alzheimer’s Disease
Blood-based biomarkers (BBMs) hold promise for a fast, convenient, and simple means to accurately diagnose Alzheimer's Disease.
top of page
Lighthouse
The New European Clinical Trials Information System
The European Medicines Agency (EMA) began mandatory use of the new Clinical Trials Information System (CTIS) as of Tuesday, Jan. 31, 2023.
Lighthouse
Cancer Care Before NGS Is Like Buying Glasses Before an Exam
Starting treatment immediately after a cancer diagnosis seems logical; however, doing so before having biomarker testing may be inadvisable.
bottom of page